8-K
filed June 18, 2026, 4:11 PM ET
ticker GH
CIK 0001576280
other material
confidence high
sentiment negative
materiality 0.15
Guardant Health annual meeting: say-on-pay proposal fails; directors elected, auditor ratified
Guardant Health, Inc.
- Directors Ian Clark and Manuel Hidalgo Medina elected with 70.5M and 81.9M votes for, respectively.
- Ratification of Deloitte as auditor approved with 115.9M votes for, 15,250 against.
- Advisory vote on executive compensation (say-on-pay) was not approved despite 98.2M for vs 9.9M against; broker non-votes 7.7M.
- Stockholders selected one year as preferred frequency for future advisory votes on exec compensation (108.0M votes for one year).
Key facts
Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Guardant Health, Inc. shareholders approved Ratification of the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026 at the 2026-06-17 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2026-06-17
Exact text from the filing
Proposal 2 in the Proxy Statement, a proposal to ratify the selection of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026, was approved by the following vote: Votes For Votes Against Abstentions 115,899,030 15,250 243,870
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Guardant Health, Inc. shareholders approved Election of the nominees for director at the 2026-06-17 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2026-06-17
Exact text from the filing
All of the nominees for director listed in Proposal 1 in the Company’s Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 28, 2026 (the “Proxy Statement”), were elected to serve on the Company’s board of directors by the following vote: Name of Nominee Votes For Votes Withheld Broker Non-Votes Ian Clark 70,526,891 37,916,548 7,714,711 Manuel Hidalgo Medina 81,925,123 26,518,316 7,714,711
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Guardant Health, Inc. shareholders rejected Advisory vote to approve the compensation of the Company’s named executive officers at the 2026-06-17 meeting.
- Proposal
- say on pay
- Outcome
- failed
- Meeting
- 2026-06-17
Exact text from the filing
Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company’s named executive officers, was not approved by the following vote: Votes For Votes Against Abstentions Broker Non-Votes 98,236,639 9,905,190 301,610 7,714,711
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 0.9
Guardant Health, Inc. shareholders approved Advisory vote on the frequency of future stockholder advisory votes regarding the compensation of the Company’s named executive officers at the 2026-06-17 meeting.
- Proposal
- say on pay frequency
- Outcome
- passed
- Meeting
- 2026-06-17
Exact text from the filing
Proposal 4 in the Proxy Statement, a proposal to determine, on an advisory (non-binding) basis, the frequency of future stockholder advisory votes regarding the compensation of the Company’s named executive officers, was determined as follows: Votes Cast for One Year Votes Cast For Two Years Votes Cast for Three Years Abstentions Broker Non-Votes 107,997,996 14,303 265,413 165,727 7,714,711
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.